Vimpat

UCB, Inc.🇺🇸 United States

FDA Page

Effective Date: May 12, 2026
Approval ID: 9e79b42c-38a3-4b2c-a196-a5a1948250e2
Products: 6 registered
Version: 63

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use VIMPAT safely and effectively. See full prescribing information for VIMPAT. VIMPAT (lacosamide) film coated tablet, for oral use, CV VIMPAT (lacosamide) injection, for intravenous use, CV VIMPAT (lacosamide) oral solution, CV Initial U.S. Approval: 2008

Quick Stats

Total Products6

Labelers2

Label Sections45

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.